Pfizer Covid-19 Vaccine Works Against Mutations Found in U.K, South Africa Variants, Lab Study Finds
laboratory study found that coronavirus mutations identified in the U.K. and South Africa had only small impacts on the effectiveness of antibodies generated by the company’s Covid-19 vaccine.
The antibodies were slightly less effective against mutations in the variant identified in South Africa, according to the study. It was posted Wednesday on the online server bioRxiv, which publishes scientific papers before they have been peer-reviewed.
Researchers have been racing to assess whether Covid-19 vaccines and drugs will still work against new variants, as governments roll out shots they hope will allow schools, businesses and other establishments to reopen.
Pfizer’s findings are consistent…